Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR004796)
Formula
SVG example
Aliphatic hydroxylation
Reactant Montelukast sodium Product Montelukast 1, 2-Diol
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C9 (CYP2C9) DME Info
Metabolic Type Oxidation - Aliphatic hydroxylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004802 Montelukast sodium 25-OH Montelukast Unclear Montelukast sodium [1]
MR004803 Montelukast sodium Montelukast ether glucuronide Unclear Montelukast sodium [1]
MR004798 Montelukast sodium Montelukast metabolite M1 Conjugation - O-glucuronidation Montelukast sodium [2], [1]
MR004799 Montelukast sodium Montelukast metabolite M2a/b Unclear Montelukast sodium [2]
MR004800 Montelukast sodium Montelukast metabolite M5a Oxidation - Hydrolyzationn Montelukast sodium [2], [1]
MR004801 Montelukast sodium Montelukast metabolite M5b Oxidation - Hydrolyzationn Montelukast sodium [2], [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004797 Montelukast 1, 2-Diol Montelukast dicarboxylic acid Unclear Montelukast sodium [1]
References
1 In vitro metabolism of montelukast by cytochrome P450s and UDP-glucuronosyltransferases. Drug Metab Dispos. 2015 Dec;43(12):1905-16.
2 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.